EpiCept Merges with Maxim to Go Public
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 64 (Table of Contents)
Published: 1 Oct-2005
DOI: 10.3833/pdr.v2005.i64.614 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Following two failed attempts at an IPO, EpiCept has now gone down the M&A route to gain a public listing by agreeing to merge with the now struggling Maxim Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018